Asia-Pacific Arachidonic Acid Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Asia-Pacific Arachidonic acid market is segmented by Technology (Solvent Extraction, Solid-Phase Extraction ), By Application (Food and Beverage (Infant Formula, Dietary Supplements), Pharmaceuticals) and by Geography

Market Snapshot

Study Period: 2016 - 2026
Base Year: 2021
CAGR: 7.4 %
CAGR% (2020 - 2025): 7.4%
Fastest Growing Segment: Food & Beverages

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Asia-Pacific Arachidonic acid market is projected to grow at a CAGR of  7.4% during the forecast period (2020 - 2025).

  • The major driver for the arachidonic acid market, is the high birth rate in countries, like India and China, which has increased its application in infant formula products, sports nutrition, and dietary supplement products, and increased in fortification of products to meet the nutritional gap.
  • Also, the increase in the number of road accidents and the growing number of cases of muscle damage are expected to boost the demand. The increasing levels of childcare awareness, baby care products, and use of ARA as sports supplements serve as the primary growth drivers for ARA market.


Scope of the Report

The arachidonic acid market is segmented by technology used which includes solvent extraction and solid-phase extraction. In the application type, the arachidonic acid market is segmented into food and beverage and pharmaceutical. The food and beverage segment is further divided into infant formula and dietary supplements. The study also involves the analysis of regions such as India, China, Australia, Japan and rest of Asia-Pacific.

By Technology
Solvent Extraction
Solid-Phase Extraction
By Application
Food and Beverage
Infant Formula
Dietary Supplements
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

ARA In Infant Formula Products Driving The Market

The Infant Formula segment of the Asia-Pacific ARA market growing at a CAGR of 6.8%, during the forecast period. In the food application, infant nutrition covers the major share in the market. ARA, as a dietary supplement, is mainly used for sports nutrition products. The nutritional requirement among infants for neurological developments during the first two years means the demand for ARA remains constant. This fact is driving the infant formula segment of the ARA market. 


China Is Major Producer Of Arachidonic Acid

China accounts for the largest share of the regional market, followed by India, Australia, and rest of Asia-Pacific. China is the world’s largest infant formula product market, which is the major factor for its large ARA consumption. China contributes to around 65% of the global infant formula market. Due to high quality, there is a growing demand for imported infant formula in the country. The Japanese market is open to international players and has advanced regulatory principles, thereby driving the growth of the arachidonic acid market. Singapore, Malaysia, and Thailand have fairly developed economies, where consumers are aware of the availability of arachidonic acid products for improving their diets.


Competitive Landscape

Asia-Pacific Arachidonic Acid Market is fragmented and prominent players are DSM, Cargill, Cabio Bioengineering, Guangdong Runke, Cayman Chemicals, among others. Advancement in biotechnology has given a good opportunity for the market. The major competitors prefer investment in new product development and marketing strategy, due to volatility in commodity costs to maintain their position.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study



    1. 3.1 Market Overview


    1. 4.1 Market Drivers

    2. 4.2 Market Restraints

    3. 4.3 Porter's Five Forces Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry


    1. 5.1 By Technology

      1. 5.1.1 Solvent Extraction

      2. 5.1.2 Solid-Phase Extraction

    2. 5.2 By Application

      1. 5.2.1 Food and Beverage

        1. Infant Formula

        2. Dietary Supplements

      2. 5.2.2 Pharmaceuticals

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. India

        2. China

        3. Australia

        4. Japan

        5. Rest of Asia-Pacific


    1. 6.1 Market Share Analysis

    2. 6.2 Company Profiles

      1. 6.2.1 Cargill. Inc

      2. 6.2.2 Cabio Biotech (Wuhan)Co., Ltd

      3. 6.2.3 Cayman Chemicals

      4. 6.2.4 Guangdong Runke

      5. 6.2.5 Royal DSM

      6. 6.2.6 A & Z Food Additives Co., Ltd

      7. 6.2.7 Zhejiang Weiss (Wecan)

      8. 6.2.8 BASF


**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Arachidonic Acid Market market is studied from 2016 - 2026.

The Asia-Pacific Arachidonic Acid Market is growing at a CAGR of 7.4% over the next 5 years.

The Asia-Pacific Arachidonic Acid Market is valued at 7.4% in 2026.

Cargill Inc., CABIO Biotech Wuhan Co Ltd, Cayman Chemical, Guangdong Runke Bioengineering Co., Ltd., Royal DSM are the major companies operating in Asia-Pacific Arachidonic Acid Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!